CLINICAL_TRIALS trial_result · 2011-05-24

Clinical Trial Update: Efficacy and Tolerability of ZD6474 in Patients With Thyroid Cancer [Phase 2]

A Phase 2 trial evaluated vandetanib (ZD6474) in thyroid cancer, focusing on efficacy and tolerability. The results were posted in May 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Genzyme, a Sanofi Company | Conditions: Thyroid Cancer | Phase 2 | Status: COMPLETED | Results posted: 2011-05-24